KomFi. Academy

easy · CFA Level I Alternative Investments

Amberfen Pharma is invested in a fund that uses 'subscription lines of credit' to bridge investments before calling capital.

The most likely impact on the J-curve is that it will:

  1. Deepen significantly as interest expenses on the credit line are added to the management fee drag.
  2. Appear shallower or delayed because the LP's cash outflows are pushed later into the fund's life.
  3. Require the fund to report under US GAAP even if it is based in a strictly IFRS jurisdiction.

Sign up free to see the explanation and track your rank →

More CFA Level I Alternative Investments practice

All Alternative Investments questions · CFA Level I study guide · CFA Level I glossary · CFA Level I flashcards